Neuraxis, Inc.
NRXS
Positions held
Your positionsNRXS isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $85.02M | Enterprise value | $76.98M | Trailing P/E | — | Forward P/E | -25.07 |
| PEG | — | Price / book | 12.54 | Beta | 1.37 | Dividend yield | 0.00% |
| Revenue growth | 115.7% | Earnings growth | — | Gross margin | 85.6% | Operating margin | -110.2% |
| Profit margin | -144.4% | ROE | -139.8% | ROA | -56.2% | Debt / equity | 0.04 |
| Current ratio | 3.04 | Free cash flow | -$3.15M | Analyst recommendation | none | Mean target | $11.00 |
| 52w high | $9.33 | 52w low | $2.21 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $1.9M | $1.6M | $1.0M | $0.8M | $0.9M | — |
| Op margin | -110.2% | -108.3% | -177.3% | -258.8% | -192.1% | — |
| Net income | -$2.1M | -$1.8M | -$1.7M | -$2.1M | -$1.7M | — |
| Gross margin | 85.9% | 86.4% | 85.4% | 83.3% | 83.6% | — |
| Gross profit | $1.7M | $1.4M | $0.8M | $0.7M | $0.7M | — |
| Operating income | -$2.1M | -$1.7M | -$1.7M | -$2.1M | -$1.7M | — |
- Revenue +20% vs prior quarter ($1.9M vs $1.6M).
- Gross margin 85.9% (was 86.4% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.6M | $2.7M | $2.5M | $2.7M | — |
| Op margin | -219.4% | -266.5% | -270.9% | -125.6% | — |
| Net income | -$7.8M | -$8.2M | -$14.6M | -$4.8M | — |
| Gross margin | 84.2% | 86.5% | 87.7% | 88.9% | — |
| Gross profit | $3.0M | $2.3M | $2.2M | $2.4M | — |
| Operating income | -$7.8M | -$7.2M | -$6.7M | -$3.4M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-16 · NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
2026-09-16 · NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference
2026-09-15 · Neuraxis Gains Nearly 137% in a Year: What's Driving the Stock?
2026-09-15 · iAccess Alpha Virtual Best Ideas Fall Investment Conference Begins Today with Updated Presentation Schedule
2026-09-12 · Is Kodak having a "Kodak moment?" 2 watchlist stocks.
2026-09-08 · iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026
2026-08-14 · NRXS Stock Dips Post Q2 Earnings Despite Revenue Surge, Gross Margin Up
2026-08-12 · NeurAxis, Inc. Q2 2026 Earnings Call Summary
2026-08-11 · Neuraxis Inc (NRXS) (Q2 2026) Earnings Call Highlights: Revenue Surges 116% as Payer Coverage ...
2026-08-11 · NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth
2026-08-10 · Earnings To Watch: Neuraxis Inc (NRXS) Q2 2026 -- GF Value Sees 55% Downside
Price (daily)
Full chart · RSI · MACD · patterns